IP Verse

Lahrtz patent opposition analysis

The comprehensive analysis of Lahrtz opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Lahrtz

Stay updated with the latest patent oppositions filed by Lahrtz

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3400241
Modulation Of Afucosylated Species In A Monoclonal Antibody CompositionOUTLOOK THERAPEUTICSApr 21, 2021ISENBRUCK BSL HRSCHLER
EP2956483
Therapeutic And Diagnostic Target For Cancer Comprising Dll3 Binding ReagentsBOEHRINGER INGELHEIMFeb 26, 2021CHUGAI SEIYAKU KABUSHIKI KAISHA
EP3121266
Oligopeptide-Free Cell Culture MediaTAKEDA PHARMACEUTICALNov 23, 2020ISENBRUCK BSL HRSCHLER
EP3030249
Antibodies, Compounds And Derivatives Thereof For Use In The Treatment Of Male InfertilityRIGSHOSPITALETSep 24, 2020ISENBRUCK BSL HRSCHLER
EP3363902
Crispr-Based Genome Modification And RegulationSIGMA ALDRICHAug 27, 2020ISENBRUCK BSL HRSCHLER
EP3398930
Method For Producing Acetic AcidDAICELAug 19, 2020CELANESE
EP2928496
Crispr-Based Genome Modification And RegulationSIGMA ALDRICHJul 9, 2020ISENBRUCK BSL HRSCHLER
EP3360964
Crispr-Based Genome Modification And RegulationSIGMA ALDRICHJul 2, 2020ISENBRUCK BSL HRSCHLER
EP2483289
Methods Of Preventing And Removing Trisulfide BondsBIOGEN IDEC MADec 18, 2019ISENBRUCK BSL HRSCHLER
EP2697251
A Method For Controlling The Main Complex N-Glycan Structures And The Acidic Variants And Variability In Bioprocesses Producing Recombinant ProteinsLEK PHARMACEUTICALS DDNov 26, 2019ISENBRUCK BSL HRSCHLER

Top clients of Lahrtz

Top companies who are the clients of Lahrtz

CompanyTotal
ISENBRUCK BSL HRSCHLER11
PATENTANWALTE ISENBRUCK BOSL HORSCHLER PARTG MBB6
CELANESE2
CHUGAI SEIYAKU KABUSHIKI KAISHA1
MERUS1